相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
Masakuni Tateyama et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Effect of Aging on Risk for Hepatocellular Carcinoma in Chronic Hepatitis C Virus Infection
Yasuhiro Asahina et al.
HEPATOLOGY (2010)
Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy
Masayuki Kurosaki et al.
HEPATOLOGY RESEARCH (2010)
Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C
Yasushi Tamura et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
Anna S. Lok et al.
GASTROENTEROLOGY (2009)
Effect of interferon α-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis
Mika Kurokawa et al.
HEPATOLOGY RESEARCH (2009)
Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels
Takashi Kumada et al.
JOURNAL OF HEPATOLOGY (2009)
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Adrian M. Di Bisceglie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection
Yasuji Arase et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C
Yasuji Arase et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: A prospective study
Kazuki Ikeda et al.
ANNALS OF INTERNAL MEDICINE (2007)
A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP
S Murashima et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
AM Di Bisceglie et al.
JOURNAL OF HEPATOLOGY (2005)
Pathogenesis of hepatitis C-associated hepatocellular carcinoma
TJ Liang et al.
GASTROENTEROLOGY (2004)
Prevention of hepatitis C virus-related hepatocellular carcinoma
EJ Heathcote
GASTROENTEROLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Sustained biochemical remission after interferon treatment may closely be related to the end of treatment biochemical response and associated with a lower incidence of hepatocarcinogenesis
K Suzuki et al.
LIVER INTERNATIONAL (2003)
Lens culinaris agglutinin-A-reactive alpha-fetoprotein as a marker for liver atrophy in fulminant hepatic failure
T Sakurai et al.
HEPATOLOGY RESEARCH (2003)
Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center
X Forns et al.
JOURNAL OF HEPATOLOGY (2001)
Serum α-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease:: influence of HBsAg and anti-HCV status
F Trevisani et al.
JOURNAL OF HEPATOLOGY (2001)
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis:: an evidence-based approach
C Cammà et al.
JOURNAL OF HEPATOLOGY (2001)
分享论文
